Please see below a list of Prof Schilling’s most recent medical publications relating to our work in AF.

 

  1. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.

    Calkins, H, Hindricks, G, Cappato, R, Kim, YH, Saad, EB, Aguinaga, L et al..

    Heart Rhythm. 2017;14 (10):e445-e494.

    PubMed PMID:31631881.

    doi: 10.1016/j.hrthm.2017.07.009.
  2. Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study.

    Banerjee, A, Benedetto, V, Gichuru, P, Burnell, J, Antoniou, S, Schilling, RJ et al..

    Heart. 2019; :.

    PubMed PMID:31601729.

    doi: 10.1136/heartjnl-2019-315307.
  3. A nurse-led implantable loop recorder service is safe and cost effective.

    Lim, WY, Papageorgiou, N, Sukumar, SM, Alexiou, S, Srinivasan, NT, Monkhouse, C et al..

    J. Cardiovasc. Electrophysiol. 2019; :.

    PubMed PMID:31578806.

    doi: 10.1111/jce.14206.
  4. STAR mapping method to identify driving sites in persistent atrial fibrillation: Application through sequential mapping.

    Honarbakhsh, S, Schilling, RJ, Finlay, M, Keating, E, Ullah, W, Hunter, RJ et al..

    J. Cardiovasc. Electrophysiol. 2019; :.

    PubMed PMID:31552697.

    doi: 10.1111/jce.14201.
  5. Full blood count as potential predictor of outcomes in patients undergoing cardiac resynchronization therapy.

    Papageorgiou, N, Falconer, D, Ioannou, A, Wongwarawipat, T, Barra, S, Tousoulis, D et al..

    Sci Rep. 2019;9 (1):13016.

    PubMed PMID:31506584. PubMed Central PMC6736835.

    doi: 10.1038/s41598-019-49659-z.
  6. British Heart Rhythm Society Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication.

    Lambiase, PD, de Bono, JP, Schilling, RJ, Lowe, M, Turley, A, Slade, A et al..

    Arrhythm Electrophysiol Rev. 2019;8 (3):161-165.

    PubMed PMID:31463053. PubMed Central PMC6702465.

    doi: 10.15420/aer.2019.8.3.G1.
  7. Ablation in Persistent Atrial Fibrillation Using Stochastic Trajectory Analysis of Ranked Signals (STAR) Mapping Method.

    Honarbakhsh, S, Hunter, RJ, Ullah, W, Keating, E, Finlay, M, Schilling, RJ et al..

    JACC Clin Electrophysiol. 2019;5 (7):817-829.

    PubMed PMID:31320010.

    doi: 10.1016/j.jacep.2019.04.007.
  8. Corrigendum to "The effect of intracoronary sodium nitrite on the burden of ventricular arrhythmias following primary percutaneous coronary intervention for acute myocardial infarction" [Int. J. Cardiol. 266 (2018) 1-6].

    Jones, DA, Rathod, KS, Williamson, A, Mand, K, Harrington, D, Andiapen, M et al..

    Int. J. Cardiol. 2019;292 :284.

    PubMed PMID:31182309.

    doi: 10.1016/j.ijcard.2019.04.076.
  9. Differentially expressed genes for atrial fibrillation identified by RNA sequencing from paired human left and right atrial appendages.

    Thomas, AM, Cabrera, CP, Finlay, M, Lall, K, Nobles, M, Schilling, RJ et al..

    Physiol. Genomics. 2019;51 (8):323-332.

    PubMed PMID:31172864. PubMed Central PMC6732415.

    doi: 10.1152/physiolgenomics.00012.2019.
  10. Implantable Cardiac Electronic Devices in the Elderly Population.

    Lim, WY, Prabhu, S, Schilling, RJ.

    Arrhythm Electrophysiol Rev. 2019;8 (2):143-146.

    PubMed PMID:31114690. PubMed Central PMC6528033.

    doi: 10.15420/aer.2019.3.4.
  11. Fluoroscopy-free cryoablation of atrial fibrillation guided solely by transoesophageal echocardiography: a case report.

    Balmforth, DC, Smith, A, Schilling, R, O'Brien, B.

    Eur Heart J Case Rep. 2018;2 (4):yty137.

    PubMed PMID:31020213. PubMed Central PMC6426113.

    doi: 10.1093/ehjcr/yty137.
  12. Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study.

    Calkins, H, Willems, S, Verma, A, Schilling, R, Hohnloser, SH, Okumura, K et al..

    Europace. 2019;21 (6):879-885.

    PubMed PMID:30982849. PubMed Central PMC6781146.

    doi: 10.1093/europace/euz057.
  13. The use of a single chamber leadless pacemaker for the treatment of cardioinhibitory vasovagal syncope.

    Roberts, PR, Pepper, C, Rinaldi, CA, Bates, MGD, Thornley, A, Somani, R et al..

    Int J Cardiol Heart Vasc. 2019;23 :100349.

    PubMed PMID:30976654. PubMed Central PMC6441741.

    doi: 10.1016/j.ijcha.2019.100349.
  14. Investigating the Complex Arrhythmic Phenotype Caused by the Gain-of-Function Mutation KCNQ1-G229D.

    Zhou, X, Bueno-Orovio, A, Schilling, RJ, Kirkby, C, Denning, C, Rajamohan, D et al..

    Front Physiol. 2019;10 :259.

    PubMed PMID:30967788. PubMed Central PMC6430739.

    doi: 10.3389/fphys.2019.00259.
  15. Strength of PLA Components Fabricated with Fused Deposition Technology Using a Desktop 3D Printer as a Function of Geometrical Parameters of the Process.

    Kuznetsov, VE, Solonin, AN, Urzhumtsev, OD, Schilling, R, Tavitov, AG.

    Polymers (Basel). 2018;10 (3):.

    PubMed PMID:30966348. PubMed Central PMC6414919.

    doi: 10.3390/polym10030313.
  16. Simultaneous Comparison of Electrocardiographic Imaging and Epicardial Contact Mapping in Structural Heart Disease.

    Graham, AJ, Orini, M, Zacur, E, Dhillon, G, Daw, H, Srinivasan, NT et al..

    Circ Arrhythm Electrophysiol. 2019;12 (4):e007120.

    PubMed PMID:30947511.

    doi: 10.1161/CIRCEP.118.007120.
  17. Multicentre randomised trial comparing contact force with electrical coupling index in atrial flutter ablation (VERISMART trial).

    Begg, GA, O'Neill, J, Sohaib, A, McLean, A, Pepper, CB, Graham, LN et al..

    PLoS ONE. 2019;14 (4):e0212903.

    PubMed PMID:30943196. PubMed Central PMC6447159.

    doi: 10.1371/journal.pone.0212903.
  18. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).

    Rohla, M, Weiss, TW, Pecen, L, Patti, G, Siller-Matula, JM, Schnabel, RB et al..

    BMJ Open. 2019;9 (3):e022478.

    PubMed PMID:30928922. PubMed Central PMC6475354.

    doi: 10.1136/bmjopen-2018-022478.
  19. The Evolving Role of Catheter Ablation in Patients With Heart Failure and AF.

    Prabhu, S, Lim, WH, Schilling, RJ.

    Arrhythm Electrophysiol Rev. 2019;8 (1):47-53.

    PubMed PMID:30918667. PubMed Central PMC6434504.

    doi: 10.15420/aer.2019.9.2.
  20. EHRA White Paper: knowledge gaps in arrhythmia management-status 2019.

    Goette, A, Auricchio, A, Boriani, G, Braunschweig, F, Terradellas, JB, Burri, H et al..

    Europace. 2019;21 (7):993-994.

    PubMed PMID:30882143.

    doi: 10.1093/europace/euz055.
  21. The impact of virtual arrhythmia clinics following catheter ablation for atrial fibrillation.

    Manimaran, M, Das, D, Martinez, P, Schwartz, R, Schilling, R, Finlay, M et al..

    Eur Heart J Qual Care Clin Outcomes. 2019;5 (3):272-273.

    PubMed PMID:30847488.

    doi: 10.1093/ehjqcco/qcz011.
  22. Development, in vitro validation and human application of a novel method to identify arrhythmia mechanisms: The stochastic trajectory analysis of ranked signals mapping method.

    Honarbakhsh, S, Hunter, RJ, Finlay, M, Ullah, W, Keating, E, Tinker, A et al..

    J. Cardiovasc. Electrophysiol. 2019;30 (5):691-701.

    PubMed PMID:30801836.

    doi: 10.1111/jce.13882.
  23. MRI for patients with cardiac implantable electronic devices: simplifying complexity with a 'one-stop' service model.

    Bhuva, AN, Feuchter, P, Hawkins, A, Cash, L, Boubertakh, R, Evanson, J et al..

    BMJ Qual Saf. 2019;28 (10):853-858.

    PubMed PMID:30760606. PubMed Central PMC6837254.

    doi: 10.1136/bmjqs-2018-009079.
  24. Regional differences in patient characteristics and outcomes during uninterrupted anticoagulation with dabigatran versus warfarin in catheter ablation of atrial fibrillation: the RE-CIRCUIT study.

    Hohnloser, SH, Calkins, H, Willems, S, Verma, A, Schilling, R, Okumura, K et al..

    J Interv Card Electrophysiol. 2019;55 (2):145-152.

    PubMed PMID:30758702. PubMed Central PMC6660508.

    doi: 10.1007/s10840-019-00518-x.
  25. Atrial fibrillation: time for active case finding.

    Robson, J, Schilling, R.

    Br J Gen Pract. 2019;69 (679):58-59.

    PubMed PMID:30704993. PubMed Central PMC6355257.

    doi: 10.3399/bjgp19X700985.
  26. Clinical impact of cardiovascular magnetic resonance with optimized myocardial scar detection in patients with cardiac implantable devices.

    Bhuva, AN, Kellman, P, Graham, A, Ramlall, M, Boubertakh, R, Feuchter, P et al..

    Int. J. Cardiol. 2019;279 :72-78.

    PubMed PMID:30642645.

    doi: 10.1016/j.ijcard.2019.01.005.
  27. Arrhythmia & Electrophysiology Review is Now the Official Journal of the British Heart Rhythm Society.

    Katritsis, DG, Schilling, R.

    Arrhythm Electrophysiol Rev. 2018;7 (4):228-229.

    PubMed PMID:30588308. PubMed Central PMC6304794.

    doi: 10.15420/aer.2018.7.4.FO2.
  28. A multicentered evaluation of ablation at higher power guided by ablation index: Establishing ablation targets for pulmonary vein isolation.

    Dhillon, G, Ahsan, S, Honarbakhsh, S, Lim, W, Baca, M, Graham, A et al..

    J. Cardiovasc. Electrophysiol. 2019;30 (3):357-365.

    PubMed PMID:30556609.

    doi: 10.1111/jce.13813.
  29. Procedural and quality assessment data on catheter ablation for fascicular ventricular tachycardia.

    Creta, A, Chow, AW, Sporton, S, Finlay, M, Papageorgiou, N, Honarbakhsh, S et al..

    Data Brief. 2018;21 :2376-2378.

    PubMed PMID:30555876. PubMed Central PMC6280585.

    doi: 10.1016/j.dib.2018.11.027.
  30. Differences in the upslope of the precordial body surface ECG T wave reflect right to left dispersion of repolarization in the intact human heart.

    Srinivasan, NT, Orini, M, Providencia, R, Simon, R, Lowe, M, Segal, OR et al..

    Heart Rhythm. 2019;16 (6):943-951.

    PubMed PMID:30550836. PubMed Central PMC6546969.

    doi: 10.1016/j.hrthm.2018.12.006.
  31. Prolonged action potential duration and dynamic transmural action potential duration heterogeneity underlie vulnerability to ventricular tachycardia in patients undergoing ventricular tachycardia ablation.

    Srinivasan, NT, Orini, M, Providencia, R, Dhinoja, MB, Lowe, MD, Ahsan, SY et al..

    Europace. 2019;21 (4):616-625.

    PubMed PMID:30500897. PubMed Central PMC6452309.

    doi: 10.1093/europace/euy260.
  32. Catheter ablation for fascicular ventricular tachycardia: A systematic review.

    Creta, A, Chow, AW, Sporton, S, Finlay, M, Papageorgiou, N, Honarbakhsh, S et al..

    Int. J. Cardiol. 2019;276 :136-148.

    PubMed PMID:30463682.

    doi: 10.1016/j.ijcard.2018.10.080.
  33. Uninterrupted anticoagulation with non-vitamin K antagonist oral anticoagulants in atrial fibrillation catheter ablation: Lessons learned from randomized trials.

    Cardoso, R, Willems, S, Gerstenfeld, EP, Verma, A, Schilling, R, Hohnloser, SH et al..

    Clin Cardiol. 2019;42 (1):198-205.

    PubMed PMID:30460702. PubMed Central PMC6436514.

    doi: 10.1002/clc.23120.
  34. A novel technique for performing transseptal puncture guided by a non-fluoroscopic 3D mapping system.

    Sawhney, V, Breitenstein, A, Watts, T, Garcia, J, Finlay, M, Lowe, M et al..

    Pacing Clin Electrophysiol. 2019;42 (1):4-12.

    PubMed PMID:30397922.

    doi: 10.1111/pace.13541.
  35. Atrial fibrillation in acute coronary syndromes: Could white blood cell count be the link?.

    Papageorgiou, N, Lim, WY, Schilling, RJ.

    Int. J. Cardiol. 2019;274 :188-189.

    PubMed PMID:30266351.

    doi: 10.1016/j.ijcard.2018.09.062.
  36. Automated detection of repetitive focal activations in persistent atrial fibrillation: Validation of a novel detection algorithm and application through panoramic and sequential mapping.

    Honarbakhsh, S, Schilling, RJ, Providencia, R, Keating, E, Sporton, S, Lowe, M et al..

    J. Cardiovasc. Electrophysiol. 2019;30 (1):58-66.

    PubMed PMID:30255666. PubMed Central PMC6378609.

    doi: 10.1111/jce.13752.
  37. Anticoagulation and the risk of complications in ventricular tachycardia and premature ventricular complex ablation.

    Lane, JD, Cannie, D, Volkova, E, Graham, A, Chow, A, Earley, MJ et al..

    Pacing Clin Electrophysiol. 2018;41 (11):1454-1460.

    PubMed PMID:30221382.

    doi: 10.1111/pace.13502.
  38. Subcutaneous implantable defibrillator in dextrocardia secondary to Lobectomy.

    Monkhouse, C, Koutsogeorgis, I, Schilling, R, Lambiase, PD.

    Clin Case Rep. 2018;6 (9):1727-1729.

    PubMed PMID:30214751. PubMed Central PMC6132161.

    doi: 10.1002/ccr3.1474.
  39. Ventricular tachycardia ablation in structural heart disease: Impact of ablation strategy and non-inducibility as an end-point on long term outcome.

    Breitenstein, A, Sawhney, V, Providencia, R, Honarbakhsh, S, Ullah, W, Dhinoja, MB et al..

    Int. J. Cardiol. 2019;277 :110-117.

    PubMed PMID:30196998.

    doi: 10.1016/j.ijcard.2018.08.099.
  40. Through-needle all-optical ultrasound imaging in vivo: a preclinical swine study.

    Finlay, MC, Mosse, CA, Colchester, RJ, Noimark, S, Zhang, EZ, Ourselin, S et al..

    Light Sci Appl. 2017;6 (12):e17103.

    PubMed PMID:30167220. PubMed Central PMC6062020.

    doi: 10.1038/lsa.2017.103.
  41. Trends in implantable cardioverter defibrillator and cardiac resynchronisation therapy lead parameters for patients with arrhythmogenic and dilated cardiomyopathies.

    Lane, JD, Whittaker-Axon, S, Schilling, RJ, Lowe, MD.

    Indian Pacing Electrophysiol J. ;19 (2):49-54.

    PubMed PMID:30145313. PubMed Central PMC6450828.

    doi: 10.1016/j.ipej.2018.08.004.
  42. Comparison of a high throughput day case atrial fibrillation ablation service in a local hospital with standard regional tertiary cardiac centre care.

    Opel, A, Mansell, J, Butler, A, Schwartz, R, Fannon, M, Finlay, M et al..

    Europace. 2019;21 (3):440-444.

    PubMed PMID:30085050.

    doi: 10.1093/europace/euy153.
  43. Structural remodeling and conduction velocity dynamics in the human left atrium: Relationship with reentrant mechanisms sustaining atrial fibrillation.

    Honarbakhsh, S, Schilling, RJ, Orini, M, Providencia, R, Keating, E, Finlay, M et al..

    Heart Rhythm. 2019;16 (1):18-25.

    PubMed PMID:30026014. PubMed Central PMC6317307.

    doi: 10.1016/j.hrthm.2018.07.019.
  44. Sudden Cardiac Death and Arrhythmias.

    Srinivasan, NT, Schilling, RJ.

    Arrhythm Electrophysiol Rev. 2018;7 (2):111-117.

    PubMed PMID:29967683. PubMed Central PMC6020177.

    doi: 10.15420/aer.2018:15:2.
  45. The effect of intracoronary sodium nitrite on the burden of ventricular arrhythmias following primary percutaneous coronary intervention for acute myocardial infarction.

    Jones, DA, Rathod, KS, Williamson, A, Harrington, D, Andiapen, M, van Eijl, S et al..

    Int. J. Cardiol. 2018;266 :1-6.

    PubMed PMID:29887423.

    doi: 10.1016/j.ijcard.2018.01.029.
  46. Thrombo-embolic events in left ventricular endocardial pacing: long-term outcomes from a multicentre UK registry.

    Sawhney, V, Domenichini, G, Gamble, J, Furniss, G, Panagopoulos, D, Lambiase, P et al..

    Europace. 2018;20 (12):1997-2002.

    PubMed PMID:29868905.

    doi: 10.1093/europace/euy107.
  47. Catheter ablation for atrial fibrillation on uninterrupted direct oral anticoagulants: A safe approach.

    Sawhney, V, Shaukat, M, Volkova, E, Jones, N, Providencia, R, Honarbakhsh, S et al..

    Pacing Clin Electrophysiol. 2018; :.

    PubMed PMID:29768672.

    doi: 10.1111/pace.13370.
  48. Ablation Index and Surround Flow Catheter Irrigation: Impedance-Based Appraisal in Clinical Ablation.

    Ullah, W, Hunter, RJ, Finlay, MC, McLean, A, Dhinoja, MB, Sporton, S et al..

    JACC Clin Electrophysiol. 2017;3 (10):1080-1088.

    PubMed PMID:29759489.

    doi: 10.1016/j.jacep.2017.03.011.
  49. Characterization of drivers maintaining atrial fibrillation: Correlation with markers of rapidity and organization on spectral analysis.

    Honarbakhsh, S, Schilling, RJ, Providencia, R, Keating, E, Chow, A, Sporton, S et al..

    Heart Rhythm. 2018;15 (9):1296-1303.

    PubMed PMID:29753943.

    doi: 10.1016/j.hrthm.2018.04.020.
  50. Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP).

    Dan, GA, Martinez-Rubio, A, Agewall, S, Boriani, G, Borggrefe, M, Gaita, F et al..

    Europace. 2018;20 (5):731-732an.

    PubMed PMID:29438514.

    doi: 10.1093/europace/eux373.
  51. A Novel Mapping System for Panoramic Mapping of the Left Atrium: Application to Detect and Characterize Localized Sources Maintaining Atrial Fibrillation.

    Honarbakhsh, S, Schilling, RJ, Dhillon, G, Ullah, W, Keating, E, Providencia, R et al..

    JACC Clin Electrophysiol. 2018;4 (1):124-134.

    PubMed PMID:29387810. PubMed Central PMC5777816.

    doi: 10.1016/j.jacep.2017.09.177.
  52. Association of genetic variation in telomere-related SNP and telomerase with ventricular arrhythmias in ischemic cardiomyopathy.

    Sawhney, V, Brouilette, S, Campbell, N, Coppen, S, Baker, V, Hunter, R et al..

    Pacing Clin Electrophysiol. 2018;41 (3):261-266.

    PubMed PMID:29344960.

    doi: 10.1111/pace.13284.
  53. Postmortem ICD interrogation in mode of death classification.

    Nikolaidou, T, Johnson, MJ, Ghosh, JM, Marincowitz, C, Shah, S, Lammiman, MJ et al..

    J. Cardiovasc. Electrophysiol. 2018;29 (4):573-583.

    PubMed PMID:29316018.

    doi: 10.1111/jce.13414.
  54. A Simplified Trans-Septal Puncture Technique using a Needle Free Approach for Cryoablation of Atrial Fibrillation.

    Honarbakhsh, S, O'Brien, B, Schilling, RJ.

    J Atr Fibrillation. ;10 (2):1628.

    PubMed PMID:29250235. PubMed Central PMC5673294.

    doi: 10.4022/jafib.1628.
  55. Diagnosis and Prognosis in Sudden Cardiac Arrest Survivors Without Coronary Artery Disease: Utility of a Clinical Approach Using Cardiac Magnetic Resonance Imaging.

    Rodrigues, P, Joshi, A, Williams, H, Westwood, M, Petersen, SE, Zemrak, F et al..

    Circ Cardiovasc Imaging. 2017;10 (12):e006709.

    PubMed PMID:29237609.

    doi: 10.1161/CIRCIMAGING.117.006709.
  56. Can Transesophageal Echocardiography Be Performed Safely Using a Laryngeal Mask Airway During Atrial Fibrillation Ablation?.

    Balmforth, D, Smith, A, Nagore, D, Schilling, R, O'Brien, B.

    J. Cardiothorac. Vasc. Anesth. 2018;32 (2):790-795.

    PubMed PMID:29229253.

    doi: 10.1053/j.jvca.2017.10.040.
  57. Fluoroscopy-free AF ablation using transesophageal echocardiography and electroanatomical mapping technology.

    O'Brien, B, Balmforth, DC, Hunter, RJ, Schilling, RJ.

    J Interv Card Electrophysiol. 2017;50 (3):235-244.

    PubMed PMID:29134434.

    doi: 10.1007/s10840-017-0288-9.
  58. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.

    Calkins, H, Hindricks, G, Cappato, R, Kim, YH, Saad, EB, Aguinaga, L et al..

    J Arrhythm. 2017;33 (5):369-409.

    PubMed PMID:29021841. PubMed Central PMC5634725.

    doi: 10.1016/j.joa.2017.08.001.
  59. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.

    Calkins, H, Hindricks, G, Cappato, R, Kim, YH, Saad, EB, Aguinaga, L et al..

    Europace. 2018;20 (1):157-208.

    PubMed PMID:29016841. PubMed Central PMC5892164.

    doi: 10.1093/europace/eux275.
  60. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

    Calkins, H, Hindricks, G, Cappato, R, Kim, YH, Saad, EB, Aguinaga, L et al..

    Europace. 2018;20 (1):e1-e160.

    PubMed PMID:29016840. PubMed Central PMC5834122.

    doi: 10.1093/europace/eux274.
  61. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.

    De Caterina, R, Brüggenjürgen, B, Darius, H, Köhler, S, Lucerna, M, Pecen, L et al..

    Arch Cardiovasc Dis. 2018;111 (2):74-84.

    PubMed PMID:28942115.

    doi: 10.1016/j.acvd.2017.04.007.
  62. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary.

    Calkins, H, Hindricks, G, Cappato, R, Kim, YH, Saad, EB, Aguinaga, L et al..

    J Interv Card Electrophysiol. 2017;50 (1):1-55.

    PubMed PMID:28914401. PubMed Central PMC5633646.

    doi: 10.1007/s10840-017-0277-z.
  63. Panoramic atrial mapping with basket catheters: A quantitative analysis to optimize practice, patient selection, and catheter choice.

    Honarbakhsh, S, Schilling, RJ, Providência, R, Dhillon, G, Sawhney, V, Martin, CA et al..

    J. Cardiovasc. Electrophysiol. 2017;28 (12):1423-1432.

    PubMed PMID:28862787.

    doi: 10.1111/jce.13331.
  64. Impact of an Age-Adjusted Co-morbidity Index on Survival of Patients With Heart Failure Implanted With Cardiac Resynchronization Therapy Devices.

    Ioannou, A, Papageorgiou, N, Barber, H, Falconer, D, Barra, S, Babu, G et al..

    Am. J. Cardiol. 2017;120 (7):1158-1165.

    PubMed PMID:28784235.

    doi: 10.1016/j.amjcard.2017.06.056.
  65. The Impact of Cryoballoon Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation on Healthcare Utilization and Costs: An Economic Analysis From the FIRE AND ICE Trial.

    Chun, KRJ, Brugada, J, Elvan, A, Gellér, L, Busch, M, Barrera, A et al..

    J Am Heart Assoc. 2017;6 (8):.

    PubMed PMID:28751544. PubMed Central PMC5586445.

    doi: 10.1161/JAHA.117.006043.
  66. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

    Calkins, H, Hindricks, G, Cappato, R, Kim, YH, Saad, EB, Aguinaga, L et al..

    Heart Rhythm. 2017;14 (10):e275-e444.

    PubMed PMID:28506916. PubMed Central PMC6019327.

    doi: 10.1016/j.hrthm.2017.05.012.
  67. Characterization and consistency of interactions of triggers and substrate at the onset of paroxysmal atrial fibrillation.

    Jones, DG, Markides, V, Chow, AWC, Schilling, RJ, Kanagaratnam, P, Wong, T et al..

    Europace. 2017;19 (9):1454-1462.

    PubMed PMID:28339601.

    doi: 10.1093/europace/euw229.
  68. Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.

    Calkins, H, Willems, S, Gerstenfeld, EP, Verma, A, Schilling, R, Hohnloser, SH et al..

    N. Engl. J. Med. 2017;376 (17):1627-1636.

    PubMed PMID:28317415.

    doi: 10.1056/NEJMoa1701005.
  69. Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants.

    Allan, V, Honarbakhsh, S, Casas, JP, Wallace, J, Hunter, R, Schilling, R et al..

    Thromb. Haemost. 2017;117 (5):837-850.

    PubMed PMID:28229164. PubMed Central PMC5442605.

    doi: 10.1160/TH16-11-0825.
  70. Validation of a High-Fidelity Electrophysiology Simulator and Development of a Proficiency-Based Simulator Training Program.

    Ullah, W, Hunter, RJ, Finlay, M, Earley, MJ, McLean, A, Marazzi, R et al..

    Simul Healthc. 2017;12 (1):41-46.

    PubMed PMID:28146452.

    doi: 10.1097/SIH.0000000000000197.
  71. Safety and mid-term outcome of catheter ablation of ventricular tachycardia in octogenarians.

    Frontera, A, Panniker, S, Breitenstein, A, Bruno, VD, Connolly, GM, Wilson, D et al..

    Europace. 2017;19 (8):1369-1377.

    PubMed PMID:27974359.

    doi: 10.1093/europace/euw236.
  72. Panoramic characterization of endocardial left atrial activation during human persistent AF: Insights from non-contact mapping.

    Lee, G, McLellan, AJ, Hunter, RJ, Lovell, MJ, Finlay, M, Ullah, W et al..

    Int. J. Cardiol. 2017;228 :406-411.

    PubMed PMID:27870970.

    doi: 10.1016/j.ijcard.2016.11.085.
  73. Adenosine-guided pulmonary vein isolation versus conventional pulmonary vein isolation in patients undergoing atrial fibrillation ablation: An updated meta-analysis.

    Papageorgiou, N, Providência, R, Srinivasan, N, Bronis, K, Costa, FM, Cavaco, D et al..

    Int. J. Cardiol. 2017;227 :151-160.

    PubMed PMID:27863291.

    doi: 10.1016/j.ijcard.2016.11.152.
  74. Medium-term outcomes of idiopathic ventricular fibrillation survivors and family screening: a multicentre experience.

    Honarbakhsh, S, Srinivasan, N, Kirkby, C, Firman, E, Tobin, L, Finlay, M et al..

    Europace. 2017;19 (11):1874-1880.

    PubMed PMID:27738067.

    doi: 10.1093/europace/euw251.
  75. Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry.

    Bakhai, A, Darius, H, De Caterina, R, Smart, A, Le Heuzey, JY, Schilling, RJ et al..

    Eur Heart J Qual Care Clin Outcomes. 2016;2 (4):299-305.

    PubMed PMID:29474715.

    doi: 10.1093/ehjqcco/qcw031.
  76. A dolus of i.v. amiodarone.

    Finlay, MC, Specterman, M, Schilling, RJ.

    Eur. Heart J. 2017;38 (17):1336-1338.

    PubMed PMID:27469374.

    doi: 10.1093/eurheartj/ehw327.
  77. Randomized trial comparing pulmonary vein isolation using the SmartTouch catheter with or without real-time contact force data.

    Ullah, W, McLean, A, Tayebjee, MH, Gupta, D, Ginks, MR, Haywood, GA et al..

    Heart Rhythm. 2016;13 (9):1761-7.

    PubMed PMID:27173976.

    doi: 10.1016/j.hrthm.2016.05.011.
  78. Endocardial biventricular defibrillator implantation in a patient with superior vena cava obstruction.

    Finlay, MC, Lall, K, Hunter, RJ, Schilling, RJ.

    Europace. 2016;18 (4):500.

    PubMed PMID:26917620. PubMed Central PMC4865057.

    doi: 10.1093/europace/euv052.
  79. Catheter ablation of atrial fibrillation in patients with heart failure: impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death.

    Ullah, W, Ling, LH, Prabhu, S, Lee, G, Kistler, P, Finlay, MC et al..

    Europace. 2016;18 (5):679-86.

    PubMed PMID:26843584.

    doi: 10.1093/europace/euv440.
  80. Point-by-Point Radiofrequency Ablation Versus the Cryoballoon or a Novel Combined Approach: A Randomized Trial Comparing 3 Methods of Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation (The Cryo Versus RF Trial).

    Hunter, RJ, Baker, V, Finlay, MC, Duncan, ER, Lovell, MJ, Tayebjee, MH et al..

    J. Cardiovasc. Electrophysiol. 2015;26 (12):1307-14.

    PubMed PMID:26727045.

    doi: 10.1111/jce.12846.
  81. The Impact of Known Heart Disease on Long-Term Outcomes of Catheter Ablation in Patients with Atrial Fibrillation and Left Ventricular Systolic Dysfunction: A Multicenter International Study.

    Prabhu, S, Ling, LH, Ullah, W, Hunter, RJ, Schilling, RJ, McLellan, AJ et al..

    J. Cardiovasc. Electrophysiol. 2016;27 (3):281-9.

    PubMed PMID:26707369.

    doi: 10.1111/jce.12899.
  82. The lung impedance monitoring in treatment of chronic heart failure (the LIMIT-CHF study).

    Domenichini, G, Rahneva, T, Diab, IG, Dhillon, OS, Campbell, NG, Finlay, MC et al..

    Europace. 2016;18 (3):428-35.

    PubMed PMID:26683599.

    doi: 10.1093/europace/euv293.
  83. Comorbidity of atrial fibrillation and heart failure.

    Ling, LH, Kistler, PM, Kalman, JM, Schilling, RJ, Hunter, RJ.

    Nat Rev Cardiol. 2016;13 (3):131-47.

    PubMed PMID:26658575.

    doi: 10.1038/nrcardio.2015.191.
  84. Monomorphic ventricular tachycardia in patients with Brugada syndrome: A multicenter retrospective study.

    Rodríguez-Mañero, M, Sacher, F, de Asmundis, C, Maury, P, Lambiase, PD, Sarkozy, A et al..

    Heart Rhythm. 2016;13 (3):669-82.

    PubMed PMID:26538325.

    doi: 10.1016/j.hrthm.2015.10.038.
  85. Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis.

    Anselmino, M, Matta, M, D'ascenzo, F, Pappone, C, Santinelli, V, Bunch, TJ et al..

    Europace. 2015;17 (10):1518-25.

    PubMed PMID:26498716.

    doi: 10.1093/europace/euv214.
  86. Use of a contact force-sensing ablation catheter with advanced catheter location significantly reduces fluoroscopy time and radiation dose in catheter ablation of atrial fibrillation.

    Lee, G, Hunter, RJ, Lovell, MJ, Finlay, M, Ullah, W, Baker, V et al..

    Europace. 2016;18 (2):211-8.

    PubMed PMID:26318548.

    doi: 10.1093/europace/euv186.
  87. The Hot and the Cold: Radiofrequency Versus Cryoballoon Ablation for Atrial Fibrillation.

    Ang, R, Domenichini, G, Finlay, MC, Schilling, RJ, Hunter, RJ.

    Curr Cardiol Rep. 2015;17 (9):631.

    PubMed PMID:26266757.

    doi: 10.1007/s11886-015-0631-7.
  88. Impact of Catheter Contact Force on Human Left Atrial Electrogram Characteristics in Sinus Rhythm and Atrial Fibrillation.

    Ullah, W, Hunter, RJ, Baker, V, Ling, LH, Dhinoja, MB, Sporton, S et al..

    Circ Arrhythm Electrophysiol. 2015;8 (5):1030-9.

    PubMed PMID:26152560.

    doi: 10.1161/CIRCEP.114.002483.
  89. Evolution of Electrocardiographic and Structural Features Over 3 Decades in Arrhythmogenic Cardiomyopathy.

    Abrams, DJ, Kirkby, C, Page, SP, Earley, MJ, Nitiou, D, Kelsell, DP et al..

    Circulation. 2015;131 (25):2233-5.

    PubMed PMID:26099957.

    doi: 10.1161/CIRCULATIONAHA.115.014371.
  90. Pulmonary vein measurements on pre-procedural CT/MR imaging can predict difficult pulmonary vein isolation and phrenic nerve injury during cryoballoon ablation for paroxysmal atrial fibrillation.

    Ang, R, Hunter, RJ, Baker, V, Richmond, L, Dhinoja, M, Sporton, S et al..

    Int. J. Cardiol. 2015;195 :253-8.

    PubMed PMID:26048388.

    doi: 10.1016/j.ijcard.2015.05.089.
  91. T-wave oversensing in patients with Brugada syndrome: true bipolar versus integrated bipolar implantable cardioverter defibrillator leads: multicenter retrospective study.

    Rodríguez-Mañero, M, de Asmundis, C, Sacher, F, Arbelo, E, Probst, V, Castro-Hevia, J et al..

    Circ Arrhythm Electrophysiol. 2015;8 (4):792-8.

    PubMed PMID:26041387.

    doi: 10.1161/CIRCEP.115.002871.
  92. Ambulatory respiratory rate trends identify patients at higher risk of worsening heart failure in implantable cardioverter defibrillator and biventricular device recipients: a novel ambulatory parameter to optimize heart failure management.

    Goetze, S, Zhang, Y, An, Q, Averina, V, Lambiase, P, Schilling, R et al..

    J Interv Card Electrophysiol. 2015;43 (1):21-9.

    PubMed PMID:25863797. PubMed Central PMC4438200.

    doi: 10.1007/s10840-015-9983-6.
  93. Increased prothrombotic profile in the left atrial appendage of atrial fibrillation patients.

    Breitenstein, A, Glanzmann, M, Falk, V, Maisano, F, Stämpfli, SF, Holy, EW et al..

    Int. J. Cardiol. 2015;185 :250-5.

    PubMed PMID:25814212.

    doi: 10.1016/j.ijcard.2015.03.092.
  94. Response to letter regarding "Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis".

    Anselmino, M, Matta, M, D'Ascenzo, F, Bunch, TJ, Schilling, RJ, Hunter, RJ et al..

    Circ Arrhythm Electrophysiol. 2015;8 (1):246.

    PubMed PMID:25691564.

    doi: 10.1161/CIRCEP.115.002697.
  95. A highly effective technique for transseptal endocardial left ventricular lead placement for delivery of cardiac resynchronization therapy.

    Domenichini, G, Diab, I, Campbell, NG, Dhinoja, M, Hunter, RJ, Sporton, S et al..

    Heart Rhythm. 2015;12 (5):943-9.

    PubMed PMID:25638701.

    doi: 10.1016/j.hrthm.2015.01.038.
  96. Relationship between contact force sensing technology and medium-term outcome of atrial fibrillation ablation: a multicenter study of 600 patients.

    Jarman, JWE, Panikker, S, DAS, M, Wynn, GJ, Ullah, W, Kontogeorgis, A et al..

    J. Cardiovasc. Electrophysiol. 2015;26 (4):378-384.

    PubMed PMID:25546580.

    doi: 10.1111/jce.12606.
  97. RE-CIRCUIT study-randomized evaluation of Dabigatran etexilate compared to warfarin in pulmonary vein ablation: assessment of an uninterrupted periprocedural anticoagulation strategy.

    Calkins, H, Gerstenfeld, EP, Schilling, R, Verma, A, Willems, S, RE-CIRCUIT Study Steering Committee et al..

    Am. J. Cardiol. 2015;115 (1):154-5.

    PubMed PMID:25456859.

    doi: 10.1016/j.amjcard.2014.10.002.
  98. Rhythm Management of the Atrial Fibrillation Patient: Practical Implementation of the 2012 ESC Guidelines.

    Mountfort, K, Kuck, KH, Schilling, R.

    Eur Cardiol. 2014;9 (2):120-122.

    PubMed PMID:30310498. PubMed Central PMC6159397.

    doi: 10.15420/ecr.2014.9.2.120.
  99. Defining disease phenotypes using national linked electronic health records: a case study of atrial fibrillation.

    Morley, KI, Wallace, J, Denaxas, SC, Hunter, RJ, Patel, RS, Perel, P et al..

    PLoS ONE. 2014;9 (11):e110900.

    PubMed PMID:25369203. PubMed Central PMC4219705.

    doi: 10.1371/journal.pone.0110900.
  100. Impact of steerable sheaths on contact forces and reconnection sites in ablation for persistent atrial fibrillation.

    Ullah, W, Hunter, RJ, McLean, A, Dhinoja, M, Earley, MJ, Sporton, S et al..

    J. Cardiovasc. Electrophysiol. 2015;26 (3):266-73.

    PubMed PMID:25346514.

    doi: 10.1111/jce.12573.
Search PubMed